Eren Tamküpeli

Medical Student | Member of EOSA @eosasocial

[Wafik S. El-Deiry, MD, PhD, FACP @weldeiry]

Books I have edited that may be of interest to those who study cancer. They are all available on Amazon.

[Eren Tamküpeli @Serentam]

@impression_ists Where Vermeer actually was born and raised. Fascinating brushstrokes.

[Eren Tamküpeli @Serentam]

@DrasmaJabeen1 Barrier points that are beneficial to touch. Thanks for sharing them Dr. Jabeen 🙌

[Eren Tamküpeli @Serentam]

@drkeithsiau I assume, pectoralis major or deltopectoral myocutaneous flap. A complication of skin-flap esophageal reconstruction also called “Hair-bearing neoesophagus” in a fancy way, I guess.

[Eren Tamküpeli @Serentam]

FISH Diagnostic Evaluation of MDM2 Amplification and Its Correlation with Radiological Images through the Eyes of an Attentive Pathologist, A good initial Example of a Multidisciplinary Approach to Malignancy. Thanks a lot for this case Dr. Kemal. @dokemal

[Kemal Kösemehmetoğlu @dokemal]

Case #49 - HacettepePathology . Case of the Month (COM)! Benign-looking malignant bone tumors! #bstpath
https://t.co/ixhDGZcXWg

[Serdar Akkol, MD PhD @sakkol_]

Happy to share that I have been chosen for the ANA Futures Program, a career development program by @TheNewANA1! Super excited for this opportunity! Academic Neurology awaits 🧠🧐 @uabneurores @uab_neurology
https://t.co/ZJ7VNobo5i

[Emre Yekedüz @yekeduz_emre]

A large population-based study with SEER and VHA data showed that overall survival has been improved over time in metastatic castration-sensitive prostate cancer patients aged under 70!

Does it show the effect of combinations or Will Rogers phenomenon?

Just my 2 cents for the former!

@JAMANetworkOpen @OncoAlert

[Eren Tamküpeli @Serentam]

@Succule85375172 👏🪴🌵🧿

[Yüksel Ürün @DrYukselUrun]

"Today's youth is rotten, evil, godless, and lazy. It will never be what youth used to be, and it will never be able to preserve our culture."

This sentiment might seem familiar:

Remarkably, this complaint is not a modern grievance but is found on a Sumerian tablet dating back to around 1000 BC.

These sentiments highlight an enduring pattern of intergenerational critique, mirroring broader societal concerns about transformation, stability, and the safeguarding of cultural traditions.
#change #leadership

[Eren Tamküpeli @Serentam]

Victory belongs to those who can say, "Victory is mine." Success belongs to those who start by saying "I will succeed" and finally say "I succeeded".

I could not have come across a more capable mentor who demonstrated to me, in real time, the veracity of this statement. 🧬

[Pinar Engin Zerk, MD @Succule85375172]

Finally 🙏🤩 #Match2024 #pathology

[Alperen Elek @ElekAlperen]

We have completed the TGRD-EVIS conference organized by the Turkish Society of IR! I am proud to have made 2 presentations at this wonderful event. After this event full of beautiful memories, I am looking forward to seeing you all next year!#EVIS #TSIR #TGRD
#Evis

[Nisa Cem Oren M.D. @oren_cem]

Combination of low carb diet with intermittent fasting and running is the beginning of a life with high quality

[Mustafa R. Dodurgali, MD @mrdodurgali]

Ending #aapmr23, a week full of education, hands-on training, and so much fun in #NOLA. It was great to connect with faculty and colleagues! Hope to see you next year in San Diego! @AAPMR

[Ekrem Çetinkaya @EkremHamid]

Proud to have ran my first ever 5K at @aapmr! Literally breathtaking 🏃‍♂️😮‍💨 views! Thanks to @mrdodurgali for motivating me to come out today 🙌🏻🏃🏃‍♀️🏃‍♂️ Congrats to everyone who came out and ran! #AAPMR23

[Nazli Dizman @NazliDizman]

🎉👏🏼 Congratulations, @yekeduz_emre! It's wonderful to see my dear friend on the podium, presenting important work under the mentorship of @DrYukselUrun, @DrChoueiri, and @OncoBellmunt and a fantastic author list incld @SylvanBacaLab @marc_eid @KarlSemaan #ValishaShah!

[Joe Gosnell, MD, MS @JGosnell2]

28 publications to date in 2023!! @UTMB_Pathology residents are absolutely crushing it with our academic output. 4 publications to go before our board is FULL! #PathMatch24 #path2path #UTMBSIR #PathMatch2024 #PathTwitter

[Hasan Çağrı Yıldırım @Hasancagri_y]

In our multecenter study presented at the #ESMO2023 , we found that there are no relationship between HER2 low status and PFS-OS for patients who receiwed palbociclib/ribociclib in first line treatment.

[Vadim Koshkin MD @koshkin85]

An amazing #ESMO2023 comes to a close. Lots of great @myESMO data for #BladderCancer pts. Looking forward to @Uromigos #nashvillelive in short 10 days @UCSFCancer @DrTFriedlander @brian_rini @tompowles1 @PGrivasMDPhD @montypal @TiansterZhang @AmandaNizamMD @shilpaonc @MattGalsky

[Tansu Eris @drtansue]

Samwise is a big fan of Prof. Rez’s insights #catsofmedicine #virtualmorningreport @CPSolvers @DxRxEdu

[WCM Englander Institute for Precision Medicine @WCMEnglanderIPM]

Check out the @UrologyTimes coverage of new #mCRPC research by Dr. Scott T. Tagawa (@DrScottTagawa), Prof. Medicine and #Urology, and an @WCMEnglanderIPM member, "Radio–antibody drug conjugate elicits antitumor activity in PSMA-positive mCRPC."

https://t.co/sYwFvF7OyG